These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34102011)

  • 1. Case of type 2 diabetes mellitus with edema resulting in subcutaneous insulin resistance syndrome.
    Hu Y; Zhu Q; Yang X; Yan J; Shi J
    J Diabetes Investig; 2021 Dec; 12(12):2267-2270. PubMed ID: 34102011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 3. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.
    Cohen D; Weintrob N; Benzaquen H; Galatzer A; Fayman G; Phillip M
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1047-50. PubMed ID: 14513883
    [No Abstract]   [Full Text] [Related]  

  • 5. Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
    Kawashima S; Kaneto H; Sakamoto K; Honsho I; Yasuda T; Kuroda A; Shiraiwa T; Kasami R; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabetes Care; 2008 Mar; 31(3):e11. PubMed ID: 18308674
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
    MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical mycobacterial infection in insulin injection sites.
    Yew TW; Chandran NS; Tan KB; Thai AC
    QJM; 2015 Aug; 108(8):673-4. PubMed ID: 25638784
    [No Abstract]   [Full Text] [Related]  

  • 10. Case of subcutaneous insulin resistance syndrome treated with ultra-rapid insulin lispro.
    Ishii T; Katayama A; Sue M; Kuribayashi R; Tenta M; Matsushita Y; Takeda M; Iseda I; Tani S; Hida K
    J Diabetes Investig; 2022 Mar; 13(3):588-591. PubMed ID: 34510782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatrics, Pens, and Pumps.
    Hieronymus L; Hepner A; Cherolis J
    Diabetes Self Manag; 2015; 32(2):20-3. PubMed ID: 26665831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipohypertrophy].
    Müssig K; Gallwitz B
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1807-8. PubMed ID: 16902904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased blood sugar in type 2 diabetes mellitus: what now?].
    Winter T
    Praxis (Bern 1994); 2002 Mar; 91(12):498-502. PubMed ID: 11974431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.
    Blanco M; Hernández MT; Strauss KW; Amaya M
    Diabetes Metab; 2013 Oct; 39(5):445-53. PubMed ID: 23886784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does size matter? Thoughts about insulin pen needles.
    Hirsch IB
    Diabetes Technol Ther; 2012 Dec; 14(12):1081. PubMed ID: 23140468
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement in severe insulin resistance with frequent injections of lispro insulin.
    Raine CH; Krzyston MJ; Amr M; Hydrick L
    J Natl Med Assoc; 1999 Jul; 91(7):410-3. PubMed ID: 10643214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A caution regarding U-500 insulin by continuous subcutaneous infusion.
    Goldberg LD
    Endocr Pract; 2004; 10(2):163, author reply 163. PubMed ID: 15256337
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation.
    Lee SI; Narendran P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from intravenous insulin to subcutaneous insulin after cardiovascular surgery: transition to target study.
    Shomali ME; Herr DL; Hill PC; Pehlivanova M; Sharretts JM; Magee MF
    Diabetes Technol Ther; 2011 Feb; 13(2):121-6. PubMed ID: 21284478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.